Vitamin C is a cofactor in the biosynthesis of carnitine, a molecule required for the oxidation of fatty acids. A reduction in the ability to oxidize fat may contribute to the reported inverse relationship between vitamin C status and adiposity. To examine this possibility, we conducted a preliminary trial to evaluate the impact of vitamin C status on fat oxidation during submaximal exercise.
Methods
Fat energy expenditure was determined in individuals with marginal (n = 15) or adequate (n = 7) vitamin C status during a submaximal, 60-minute treadmill test. Subsequently, eight of the subjects with marginal vitamin C status completed an 8-week double-blind, placebo-controlled, depletion-repletion trial with submaximal exercise testing.
Results
Individuals with marginal vitamin C status oxidized 25% less fat per kg body weight during the treadmill test as compared to individuals with adequate vitamin C status. Fat oxidation during exercise was inversely related to fatigue (r = -0.611, p = 0.009). Vitamin C repletion of vitamin C depleted subjects (500 mg vitamin C/d) raised fat energy expenditure during exercise 4-fold as compared to depleted control subjects (p = 0.011).
Conclusion
These preliminary results show that low vitamin C status is associated with reduced fat oxidation during submaximal exercise. Low vitamin C status may partially explain the inverse relationship between vitamin C status and adiposity and why some individuals are unsuccessful in their weight loss attempts.
Background
About 15% of US adults are vitamin C deficient (plasma vitamin C < 11 μmol/L) [1]. Twenty-five years ago, this percentage was much lower, 3–5% of US adults [2]. Concomitant with this recent rise in the prevalence of vitamin C deficiency, America experienced a major epidemic of overweight and obesity [3]. Indeed, survey data suggest an inverse relationship between vitamin C status and body weight [4, 5] and waist measurements [6]. The underlying systemic oxidative stress associated with obesity has been proposed to explain the inverse relation between adiposity and plasma vitamin C concentrations [6]. Since vitamin C is an essential cofactor for the biosynthesis of carnitine, a molecule required for the oxidation of fatty acids [7, 8], a reduction in the ability to oxidize fat may contribute to the relationship between vitamin C status and adiposity. To examine this possibility, we conducted a preliminary trial to evaluate the impact of vitamin C nutriture on fat oxidation during submaximal exercise in a small sample of young adults.
Methods
Seventy-eight sedentary, non-smoking men and women, aged 18–38 y, from a campus population were screened for plasma vitamin C status. Nearly 40% of the sample had marginal vitamin C status (n = 30; plasma vitamin C concentration <34 μmol/L), and 15 of these individuals (mean age, 21.1 ± 0.8 y) agreed to participate in exercise testing. An additional 7 of the screened individuals with adequate vitamin C status (plasma vitamin C concentration ≥ 34 μmol/L) were included as the vitamin C adequate (control) group. All participants provided informed consent, and the study was conducted in accordance with the guidelines of the University Institutional Review Board.
Participants were free of medical conditions contraindicated for exercise testing as set by guidelines of the American College of Sports Medicine. Participants did not regularly use nutritional supplements and were unaware of their vitamin C status or the intent of the study. Maximal oxygen consumption (VO2 max) using a graded walking protocol was determined. Within 7–10 days of VO2 max testing, participants returned to the laboratory for a submaximal, 60-minute treadmill walk at 50% of their VO2 max. Participants were instructed to fast for 4–6 h prior to the exercise test and to remain sedentary for the previous 24 h period. Urine samples were collected pre- and post-exercise to assess urea nitrogen. During the exercise test, oxygen consumption and respiratory exchange ratio (RER) were measured from three minute gas samples collected at 10 minute intervals corresponding to minutes 7–10, 17–20, 27–30, etc. Substrate utilization was then calculated using the non-protein respiratory quotient derived from the urinary nitrogen and metabolic (VO2 and VCO2) measures. The data reported represent averaged values from samples collected at steady state toward the end of exercise (i.e., 37, 47, and 57 minutes). Immediately after testing, participants completed the POMS questionnaire (Profile of Moods States; EdiTS/Educational and Industrial Testing Service, San Diego, CA).
Intervention trial
Eight of the 15 participants with marginal vitamin C status agreed to participate in an 8-week intervention trial. These subjects maintained their usual dietary patterns; however, they were provided with a list of foods to avoid during the trial. [Although not revealed to the subjects, these foods contained >30 mg of vitamin C per serving.] During weeks 1–4, all participants ingested a placebo capsule daily. At the end of this depletion period, subjects completed a submaximal, 60-minute treadmill walk as described above. Starting at week 5, the participants were randomly assigned to receive a placebo capsule (depleted group; n = 3) or a 500 mg vitamin C capsule (repleted group; n = 5) daily. A double-blind protocol was followed, and the placebo and vitamin C capsules were identical in appearance. At the end of week 8, participants completed a 60-minute treadmill walk. Within one week of the completion of the trial, participants completed a second VO2 max test utilizing the procedures outlined above. Fasting blood samples were collected at weeks 5 and 8. An aliquot of plasma was deproteinized in 10% TCA and frozen at -45°C until analyzed for vitamin C using 2,4-dinitrophenylhydrazine [9]. Plasma free carnitine was measured radiochemically [10], and urinary urea nitrogen was measured colorimeterically.
Data are reported as mean ± SE, and statistical analyses were performed using SPSS for WINDOWS (version 12; SPSS Inc, Chicago). Differences between means were assessed using an independent t-test, and the Pearson's correlation was used to identify relationships between variables. Significance was set at p ≤ 0.05.
Results
Data from the descriptive study showed that RER during submaximal exercise was significantly higher for individuals with marginal vitamin C status as compared to the vitamin C adequate controls (p = 0.034; Table 1). Furthermore, fat oxidation during exercise was reduced 25% for the marginal versus adequate vitamin C groups (p = 0.045). Plasma free carnitine was significantly lower in the controls as compared to the subjects with marginal vitamin C status (Table 1). (Although carnitine concentrations in muscle are directly related to vitamin C status, plasma carnitine concentrations appear to be inversely related to vitamin C status [11].) Fat oxidation during the walking test was inversely correlated to fatigue as scored by the POMS questionnaire (r = -0.611, p = 0.009) and to plasma carnitine (r = -0.489, p = 0.034). Plasma vitamin C was inversely related to plasma carnitine (r = -0.794, p = 0.000), but the correlation between plasma vitamin C and fat oxidation or RER did not achieve significance (r = 0.309 and r = -0.329 respectively).
Intervention trial
Plasma vitamin C concentrations after the depletion period (weeks 1–4) averaged 12.3 ± 3.5 μmol/L. Following the randomized intervention period (weeks 5–8), plasma vitamin C concentrations differed significantly between the repleted and depleted groups (41.7 ± 0.9 and 9.7 ± 1.0 μmol/L respectively, p < 0.001; Figure 1). Fat oxidation was also significantly different by group at week 8 (2.03 ± 0.37 and 0.48 ± 0.11 kcals/kg for the repleted and depleted groups respectively, p = 0.011; Figure 1), and protein oxidation was elevated at week 8 in the depleted group as compared to the repleted group (0.89 ± 0.28 and 0.37 ± 0.08 kcals/kg respectively, p = 0.062).
When week 4 and week 8 data were combined, plasma vitamin C concentrations were inversely related to protein energy expenditure (r = -0.679, p = 0.004) and directly related to fat energy expenditure (r = 0.655, p = 0.006). Plasma carnitine was weakly related to plasma vitamin C (r = -0.441, p = 0.087). A training effect was not evident in participants since pre- and post-trial VO2 max values were similar (34.3 ± 3.7 and 36.7 ± 7.9 ml/kg/min versus 32.9 ± 4.1 and 34.9 ± 6.7 ml/kg/min for the repleted and depleted groups respectively at pre-trial versus post-trial).
Discussion
These preliminary data indicate that vitamin C status impacts fat oxidation. Free-living individuals with marginal vitamin C status oxidized 25% less fat per kg body weight during a 60-minute treadmill walk as compared to individuals with adequate vitamin C status. Moreover, fat oxidation during exercise was enhanced in these individuals by normalizing plasma vitamin C concentrations. Vitamin C is a cofactor for two enzymes required for the biosynthesis of carnitine, ε-N-trimethyl-L-lysine hydroxylase and γ-butyrobetaine hydroxylase [12–15]. Since the oxidation of fatty acids in skeletal muscle is dependent on carnitine [7, 8], this is a possible mechanism by which vitamin C affects fat oxidation. We also observed a reduction in protein oxidation in the vitamin C repleted subjects which is consistent with the protein-sparing effect of supplemental carnitine [16].
Numerous trials have demonstrated that tissue carnitine levels are directly related to vitamin C nutriture [11, 17, 18], and that plasma vitamin C and carnitine concentrations are inversely related [11, 19]. However, to our knowledge, only one other study has examined the relationship between vitamin C, carnitine metabolism, and fat oxidation [20]. In cultured hepatocytes, Ha et al. demonstrated that ascorbic acid directly stimulated carnitine synthesis and the β-oxidation of fatty acids, and reduced triglyceride accumulation [20]. This observation that vitamin C reduces fat deposition may explain the reported inverse relationship between adiposity and vitamin C status [4–6]. Interestingly, in patients with an inborn error of carnitine metabolism, carnitine deficiency is associated with lipid accumulation in tissues [21–23]. In fact, activation of the carnitine system has been cited as a possible treatment for obesity [24–26].
Carnitine deficiency is also associated with fatigue and exercise intolerance [21–23], and Hughes et al postulated several decades ago that the lassitude and tiredness of scurvy may be attributed to carnitine deficiency [17]. Our data indicated that reduced fat oxidation during exercise was related to fatigue. It is tempting to speculate that the reduced fat oxidation associated with vitamin C depletion may result in weight gain by two mechanisms: indirectly by fatigability and exercise intolerance and directly by lipid accumulation. Since 15% of Americans are reportedly vitamin C deficient, and one-third of Americans have below adequate vitamin C status [1, 27], these issues deserve further investigation.
Our study had several limitations. The sample sizes were small, 22 for the descriptive study and eight for the intervention trial, which limits the generalizability of results. Furthermore, muscle carnitine, the most sensitive marker of tissue carnitine status, was not assessed in this trial. Also, since vitamin C is a required cofactor for dopamine beta-hydroxylase [28], altered norepinephrine responses in vivo may have impacted fat oxidation in this trial [see [29]].
Conclusion
These preliminary results show that low vitamin C status may reduce fat oxidation during submaximal exercise and that reduced fat oxidation during exercise was related to fatigue. It is possible that increased fatigue and less reliance on fat as a fuel during activity may influence eventual weight gain. Thus, in addition to emphasizing calorie control and physical activity, attention to specific diet components such as vitamin C may be necessary for effective weight management.
Abbreviations
RER: respiratory exchange ratio
Figure 1
Individual subject data for plasma vitamin C concentration (A) and for fat energy (B) and protein energy (C) expended during submaximal exercise in vitamin C depleted (placebo capsule daily; n = 3) and vitamin C repleted (500 mg vitamin C capsule daily; n = 5) subjects at week 4 (pre-intervention) and week 8 (post-intervention). Means (± SE) are shown in black bars; *p < 0.05; **p = 0.062 (independent t-test)
Table 1
Baseline characteristics for subjects with marginal (n = 15) or adequate (n = 7) vitamin C status
Marginal vitamin C status Plasma vitamin C <34 μmol/L
Adequate vitamin C status Plasma vitamin C ≥34 μmol/L
p value1
Vitamin C, μmol/L
18.1 ± 2.5
42.9 ± 3.4
.000
BMI, kg/m2
25.0 ± 1.3
23.3 ± 1.4
.436
Total carnitine, ng/ml
12.0 ± 0.8
6.5 ± 0.9
.000
RER2
0.87 ± 0.02
0.83 ± 0.01
.034
Fat energy*, kcals/kg
1.02 ± 0.12
1.36 ± 0.11
.045
VO2max*, ml/kg/min
37.5 ± 2.5
36.9 ± 2.3
.866
1Independent t-test.
2Computed at steady state during 60-minute submaximal walk test.
Declarations
Authors’ Affiliations
(1)
Department of Nutrition, Arizona State University
(2)
Department of Exercise and Wellness, Arizona State University
References
Hampl JS, Taylor CA, Johnston CS: Vitamin C deficiency and depletion in the United States: the Third National Health and Nutrition Examination Survey, 1988–1994. Am J Pub Health. 2004, 94: 870-875.View ArticleGoogle Scholar
U.S. Department of Health and Human Services: Hematological and nutritional biochemistry reference data for persons 6 months-74 years of age. United States, 1976–1980. Advance Data from Vital and Health Statistics, No. 83-1682. 1982, Hyattsville, Md. National Center for Health Statistics, 124-139.Google Scholar
Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL: Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord. 1998, 22: 39-47. 10.1038/sj.ijo.0800541.View ArticleGoogle Scholar
Kant AK: Interaction of body mass index and attempt to lose weight in a national sample of US adults: association with reported food and nutrient intake, and biomarkers. Eur J Clin Nutr. 2003, 57: 249-259. 10.1038/sj.ejcn.1601549.View ArticleGoogle Scholar
Moor de Burgos A, Wartanowicz M, Ziemlanski S: Blood vitamin and lipid levels in overweight and obese women. Eur J Clin Nutr. 1992, 46: 803-808.Google Scholar
Canoy D, Wareham N, Welch A, Bingham S, Luben R, Day N, Khaw KT: Plasma ascorbic acid concentrations and fat distribution in 19 068 British men and women in the European Prospective Investigation into Cancer and Nutrition Norfolk cohort study. Am J Clin Nutr. 2005, 82: 203-209.Google Scholar
Reda E, D'Iddio S, Nicolai R, Benatti P, Calvani M: The carnitine system and body composition. Act Diabetol. 2003, 40: S106-113. 10.1007/s00592-003-0040-z.View ArticleGoogle Scholar
Hoppel C: The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis. 2003, 41 (4 Suppl 4): S4-12.View ArticleGoogle Scholar
Omaye ST, Turnbull JD, Sauberlich HE: Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol. 1979, 62: 3-11.View ArticleGoogle Scholar
Pace JA, Wannemacher RW, Neufeld HA: Improved radiochemical assay for carnitine and its derivatives in plasma and tissue extracts. Clin Chem. 1978, 24: 32-35.Google Scholar
Sandor A, Kispal G, Kerner J, Alkonyi I: Combined effect of ascorbic acid deficiency and underfeeding on the hepatic carnitine level in guinea-pigs. Experientia. 1983, 39: 512-513. 10.1007/BF01965181.View ArticleGoogle Scholar
Rebouche CJ: Ascorbic acid and carnitine biosynthesis. Am J Clin Nutr. 1991, 54 (6 Suppl): 1147S-1152S.Google Scholar
Dunn WA, Rettura G, Seifter E, Englard S: Carnitine biosynthesis from gamma-butyrobetaine and from exogenous protein-bound 6-N-trimethyl-L-lysine by the perfused guinea pig liver. Effect of ascorbate deficiency on the in situ activity of gamma-butyrobetaine hydroxylase. J Biol Chem. 1984, 259: 10764-10770.Google Scholar
Rebouche CJ, Paulson DJ: Carnitine metabolism and function in humans. Ann Rev Nutr. 1986, 6: 41-66. 10.1146/annurev.nu.06.070186.000353.View ArticleGoogle Scholar
Heo K, Odle J, Han IK, Cho W, Seo S, van Heugten E, Pilkington DH: Dietary L-carnitine improves nitrogen utilization in growing pigs fed low energy, fat-containing diets. J Nutr. 2000, 130: 1809-1814.Google Scholar
Hughes RE, Hurley RJ, Jones E: Dietary ascorbic acid and muscle carnitine (beta-OH-gamma-(trimethylamino) butyric acid) in guinea-pigs. Br J Nutr. 1980, 43: 385-387. 10.1079/BJN19800102.View ArticleGoogle Scholar
Sartorelli L, Ciman M, Mantovani G, Siliprandi N: Carnitine transport in rat heart slices: II. The carnitine/deoxycarnitine antiport. Ital J Biochem. 1985, 34: 282-287.Google Scholar
Johnston CS, Solomon RE, Corte C: Vitamin C depletion is associated with alterations in blood histamine and plasma free carnitine in adults. J Am Coll Nutr. 1996, 15: 586-591.View ArticleGoogle Scholar
Ha TY, Otsuka M, Arakawa N: Ascorbate indirectly stimulates fatty acid utilization in primary cultured guinea pig hepatocytes by enhancing carnitine synthesis. J Nutr. 1994, 124: 732-737.Google Scholar
Foster DW: The role of the carnitine system in human metabolism. Ann NY Acad Sci. 2004, 1033: 1-16. 10.1196/annals.1320.001.View ArticleGoogle Scholar
Ronnett GV, Kim EK, Landree LE, Tu Y: Fatty acid metabolism as a target for obesity treatment. Physiol Behav. 2005, 85: 25-35. 10.1016/j.physbeh.2005.04.014.View ArticleGoogle Scholar
Cherian MA, Santoro TJ: The role of saturation of fat depots in the pathogenesis of insulin resistance. Med Hypotheses. 2005,Google Scholar
Johnston CS, Thompson LL: Vitamin C status of an outpatient population. J Am Coll Nut. 1998, 17: 366-370.View ArticleGoogle Scholar
Menniti FS, Knoth J, Diliberto EJ: Role of ascorbic acid in dopamine beta-hydroxylation. The endogenous enzyme cofactor and putative electron donor for cofactor regeneration. J Biol Chem. 1986, 25: 16901-16908.Google Scholar
Qvisth V, Hagstrom-Toft E, Enoksson S, Moberrg E, Arner P, Bolinder J: Human skeletal muscle lipolysis is more responsive to epinephrine than to norepinephrine stimulation in vivo. J Clin endocrinol Metab. 2006, 91: 665-670. 10.1210/jc.2005-0859.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
